Cited by 11Peripheral Artery Disease ManagementHealth Promotion and Cardiovascular PreventionVascular Procedures and Complications

Peripheral Artery Disease Screening in the Community and 1-Year Mortality, Cardiovascular Events, and Adverse Limb Events

Open access
Smolderen, Kim G., Ameli, Omid, Chaisson, Christine E., Heath, Kevin, Mena-Hurtado, Carlos·2022·AJPM Focus

Abstract

Introduction: This study aimed to examine all-cause mortality, 1- and 2-year major cardiovascular events, and major adverse limb events in individuals aged ≥65 years who received an in-home health visit with peripheral artery disease screening. In addition, we compared 1-year healthcare utilization before and after peripheral artery disease screening for those who screened positive. Setting/Participants: Medicare Advantage beneficiaries aged ≥65 years participating in the Optum HouseCalls program in the U.S. between April 1, 2017 and February 1, 2019 were included. Intervention: The intervention consisted of a peripheral artery disease screening program using a plethysmography system. Main outcome measures: One-year all-cause mortality as a landmark analysis, 1- and 2-year major cardiovascular events, and major adverse limb events after screening were compared by peripheral artery disease screen status using claims data. We compared cardiovascular medications and revascularization procedures between the year before and after the peripheral artery disease screening event for those with peripheral artery disease. Results: <0.001; adjusted hazard ratio=1.21; 95% CI=1.08, 1.36) as well as 1-year major cardiovascular events (5.54% vs 3.60%; adjusted hazard ratio= 1.22; 95% CI=1.15, 1.30) and major adverse limb events (0.23% vs 0.04%; adjusted hazard ratio=3.15; 95% CI=2.10, 4.73). Similar risks were observed for 2-year results. Before and after peripheral artery disease screening, medications remained stable for those who screened positive (e.g., statin therapy=54.2% vs 56.6%); rates of peripheral vascular interventions remained stable (0.0% vs 0.1%). Conclusions: A national peripheral artery disease screening effort is feasible. Detecting previously undiagnosed peripheral artery disease is a way to risk stratify a population that would benefit from further cardiovascular risk management.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.focus.2022.100016

Cites

33 of 33 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • A positive screening test for PAD in an asymptomatic population has been associated with increased cardiovascular event rates.

    “While a positive screening test for PAD in an asymptomatic population has been associated with increased cardiovascular event rates (241,242), prospective, randomized studies addressing whether screening for PAD in people with diabetes improves longterm limb outcomes and cardiovascular event rates are limited.”

    From 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2025 (2025) · cites this paper as [241]

    The Results report higher 1-year major adverse cardiovascular event rates after a positive PAD screen than after a negative screen (5.54% versus 3.60%). The Discussion describes participants as previously unknown to have PAD, but does not establish that the screened population was asymptomatic; that qualifier is not supported. (LLM, conf=0.84)

    Experimental — accuracy not yet measured
  • A positive screening test for PAD in an asymptomatic population has been associated with increased cardiovascular event rates.

    “While a positive screening test for PAD in an asymptomatic population has been associated with increased cardiovascular event rates (230,231), prospective, randomized studies addressing whether screening for PAD in”

    From 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2026 (2026) · cites this paper as [230]

    The Results report higher major adverse cardiovascular event rates after a positive PAD screen than after a negative screen. The Discussion describes participants as previously unknown to have PAD, but does not establish that the screened population was asymptomatic; that qualifier is not supported. (LLM, conf=0.85)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

1 of the 34 references couldn’t be matched to a known paper.

Research works printed but not linked: 1

  1. [26]Wooldridge J. Econometric Analysis of Cross Section and Panel Data 2nd ed 2010 MIT Press

Cited by

Sorted by citations

Authors
Smolderen, K. G., Ameli, O., Chaisson, C. E., Heath, K., & Mena-Hurtado, C.
Affiliations
  • Yale University (US)
  • Optum (United States) (US)
Corresponding author
Smolderen, Kim G.
Venue
AJPM Focus
Publisher
Elsevier BV
Published
2022-09
Volume
1
Issue
1
Pages
100016
ISSN
2773-0654 (ISSN-L)
OpenAlex
W4288046001
Cited by
11
References
34
Citations by year
2026: 3 · 2025: 3 · 2024: 3 · 2023: 2
FWCI
1.91
Type
journal article
Language
en
Open access
Locations
  • AJPM Focus (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
UnitedHealth Group Inc
Topics
  • Health Sciences › Medicine › Surgery › Peripheral Artery Disease Management
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Health Promotion and Cardiovascular Prevention
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Vascular Procedures and Complications
Keywords
peripheral arterial disease, screening, all-cause mortality, major cardiovascular events, major adverse limb events, plethysmography, Medicare Advantage beneficiaries, older adults, cardiovascular risk stratification, health care utilization, revascularization

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review